Front. Immunol. Frontiers in Immunology Front. Immunol. 1664-3224 Frontiers Media S.A. 10.3389/fimmu.2021.748756 Immunology Erratum Erratum: Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome Frontiers Production Office * Frontiers Media SA, Lausanne, Switzerland

Approved by:Frontiers Editorial Office, Frontiers Media SA, Switzerland

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

This article was submitted to Autoimmune and Autoinflammatory Disorders, a section of the journal Frontiers in Immunology

 10 08 2021 2021 12 748756 28 07 2021 28 07 2021 Copyright © 2021 Frontiers Production Office 2021 Frontiers Production Office

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 An Erratum on: Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome Staels F, Betrains A, Woei-A-Jin FJSH, Boeckx N, Beckers M, Bervoets A, Willemsen M, Neerinckx B, Humblet-Baron S, Blockmans DE, Vanderschueren S and Schrijvers R (2021). Front. Immunol. 12:678927. doi: 10.3389/fimmu.2021.678927 primary immunodeficiencies autoinflammation treatment reactions myelodysplasia ubiquitination

Due to a production error, an author name was incorrectly written as “Sherida Woei-A-Jin”, which did not match the citation. The correct name is “F J Sherida H Woei-A-Jin”. The publisher apologizes for this mistake.

The original version of this article has been updated.